B Safety & quality
Patient Safety & Product Quality
We constantly monitor the safety and efficacy of our products for continual product quality improvement. Select a topic to see how to reach the right team.
Tel: +46 702 62 38 52
or E-mail: pv@ometpharma.com
Report a suspected side effect directly to the national medicines authority in your country. Each authority’s reporting service is available in the local language.
- Sweden — Läkemedelsverket
- Denmark — Lægemiddelstyrelsen
- Finland — Fimea
- Iceland — Icelandic Medicines Agency
- Norway — DMP (from 2027)
Alternatively: Tel: +46 702 62 38 52 or E-mail: pv@ometpharma.com
Tel: +46 702 62 38 52
or E-mail: info@ometpharma.com
Further information is available from the national medicines authorities:
Iceland — Icelandic Medicines Agency
We are constantly monitoring the safety and efficacy of our products for continual product quality improvement.